PapersPMID:40917356
Potential role of 4-hydroxyisoleucine in enhancing fertility in male mice with diet-induced obesity.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- animal · not in humans · 6 weeks
What moved
How to read these marks →- Decreases body mass
insufficient
“Consistent with previous reports, we observed that 4-HIL treatment significantly reduced the body weight of mice in the HFD group compared to HFD mice without treatment.”
- Dose studied
- 4-hydroxyisoleucine 200 mg/kg/day by intraperitoneal injection in 0.3 ml saline per 30 g body weight for six weeks; control HFD mice received saline injections
- Population
- male C57BL/6 mice with high-fat-diet-induced obesity (10 weeks HFD), high-fat diet continued in both arms
“In addition, inflammatory markers, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFα), were assessed, and their serum and testis concentrations were found to be reduced in 4-HIL treated mice compared to those in HFD mice (Supplementary Figures S2C, D).”
- Decreases interleukin-6 concentration
insufficient
- Dose studied
- 4-hydroxyisoleucine 200 mg/kg/day by intraperitoneal injection for six weeks; control HFD mice received saline injections
- Population
- male C57BL/6 mice with high-fat-diet-induced obesity, high-fat diet continued in both arms
- Dose studied
- 4-hydroxyisoleucine 200 mg/kg/day by intraperitoneal injection for six weeks; control HFD mice received saline injections
- Population
- male C57BL/6 mice with high-fat-diet-induced obesity, high-fat diet continued in both arms
Study record
- Design
- animal study, in vivo
- Species
- animal
- Population
- C57BL/6 male mice with high-fat-diet-induced obesity (60% HFD for 10 weeks), then 6 weeks of intraperitoneal 4-hydroxyisoleucine (Aladdin Scientific, CAS 781658-23-9) versus saline; normal-diet controls
- Participants
- 45
- Comparator
- no treatment / placebo
- Duration
- 42 days
- Endpoints measured
- 29